Health Care/Hospital
UC Berkeley and Bitmark launch Autonomy app as part of the school's COVID-19 Safe Campus Initiative
BERKELEY, Calif., Sept. 22, 2020 /PRNewswire/ -- As part of UC Berkeley's Safe Campus Initiative, the university and BitmarkInc. have partnered to launch Autonomy, a public health app that helps users understand how their local community is managing with COVID-19. In the process, Autonomy enables...
2020-09-22 22:00
1951
Jennewein Biotechnologie GmbH and Chr. Hansen A/S to join forces in high-growth Human Milk Oligosaccharides market
RHEINBREITBACH and BONN, Germany, Sept. 22, 2020 /PRNewswire/ -- Jennewein Biotechnologie GmbH agreed to join forces with Chr. Hansen Holding A/S, a leading bioscience company based in Hoersholm/Denmark, to lead the global market for human milk oligosaccharides (HMOs). Chr. Hansen entered into an...
2020-09-22 21:36
2979
Biorasi Commended by Frost & Sullivan for its Full-service Offering to Drive Rare Disease Patient Recruitment for CROs
SANTA CLARA, California, Sept. 22, 2020 /PRNewswire/ -- Based on its recent analysis of the North American contract research organization (CRO) market, Frost & Sullivan recognizesBiorasi, LLC with the 2020 North American Entrepreneurial Company of the Year Award. Biorasi's milestone-based, patie...
2020-09-22 21:00
2203
Switching to investigational once-weekly insulin icodec from other basal insulins demonstrated to be efficacious and well-tolerated for people with type 2 diabetes in phase 2 trial
BAGSVAERD, Denmark, Sept. 22, 2020 /PRNewswire/ -- Today, Novo Nordisk announced results from three phase 2 clinical trials for insulin icodec, an investigational once-weekly basal insulin analogue, which were presented during the 56th European Association for the Study of Diabetes (EASD) Annual ...
2020-09-22 20:53
3001
New Study Suggests GlycoMark® May Identify Highest Risk Patients with Prediabetes
RALEIGH, North Carolina, Sept. 22, 2020 /PRNewswire/ -- According to new data presented at the 56th European Association for the Study of Diabetes (EASD) annual meeting, the GlycoMark blood test reflects beta-cell functional mass, which is important in identifying prediabetic individuals with the...
2020-09-22 19:00
1853
TCM Lianhua Qingwen Capsule approved for registration in Mauritius
SHIJIAZHUANG, China, Sept. 22, 2020 /PRNewswire/ -- Yiling Pharmaceutical Co., Ltd. (SHE: 002603) announced on Tuesday that it has received a registration approval issued by the Ministry of Health and Wellness ofMauritius, indicating Lianhua Qingwen Capsule has been registered in accordance with ...
2020-09-22 15:21
1908
Gates Foundation Honors Director of Africa CDC With 2020 Global Goalkeeper Award
Foundation also announces three Global Goals award winners and launches two innovative partnerships to address COVID-19 impacts inKenya SEATTLE, Sept. 22, 2020 /PRNewswire/ -- The Bill & Melinda Gates Foundation today named Dr. John N. Nkengasong, director of the Africa Centres for Disease Contr...
2020-09-22 12:01
3103
Kazia Enters Clinical Collaboration With Dana-farber Cancer Institute For Primary CNS Lymphoma
SYDNEY, Sept. 22, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it has entered into a collaboration with Dana-Farber Cancer Institute (DFCI) inthe United States, to investigate the use of...
2020-09-22 09:21
7859
Samsung Biologics and AstraZeneca forge strategic manufacturing partnership for global supply
INCHEON, South Korea, Sept. 21, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and AstraZeneca announced a long-term supply agreement, valued at approximately $330.8 million. Under this agreement, Samsung Biologics will provide large-scale commercial manufacturing for drug substance in its Pla...
2020-09-22 07:00
12805
Israeli Pain Monitoring Startup Medasense Raises $18M in Series C Round
Accelerating Commercialization of its Novel Pain Monitoring Solutions RAMAT GAN, Israel, Sept. 22, 2020 /PRNewswire/ -- Medasense Biometrics Ltd., developer of the NOL technology for pain-response monitoring, today announced that it has raised$18M in a series C round, from Sabadell Asabys venture...
2020-09-22 06:30
3201
Vection Secures First Hospital Trial
PERTH, Australia, Sept. 22, 2020 /PRNewswire/ -- Real-time software company Vection Technologies Ltd (ASX:VR1) has signed a first public hospital to trial its Augmented Reality healthcare solutions. Vection Technologies will collaborate with the AORN S.G. Moscati hospital and LUISS Business Sch...
2020-09-22 06:17
2877
Qatar Foundation's WISE Announces Special E-Book
Education Disrupted, Education Reimagined - Responses from education's frontline during the COVID-19 pandemic and beyond DOHA, Qatar, Sept. 22, 2020 /PRNewswire/ -- WISE, a Qatar Foundation global education think-tank, in partnership with Salzburg Global Seminar, and Diplomatic Courier, is pleas...
2020-09-22 06:14
4045
Alcohol Detection Anklets Showing Promise in NZ
With COVID-19, Incidents of Alcohol Abuse Reportedly on the Rise AUCKLAND, New Zealand, Sept. 22, 2020 /PRNewswire/ -- Alcohol Detection Anklets (ADA) are garnering a lot of attention in New Zealand and Australia for helping alcohol-involved clients refrain from drinking. The anklets use transde...
2020-09-22 04:24
2426
Amazfit Band 5 Launched with Blood Oxygen Saturation, 15-day Battery Life[1] at 49.9USD[2] on Sept. 21st, and Amazon Alexa Built-in[3] Coming Soon
Can A Band Be Smarter? Check this All-round Band with Varied Health Management and Alexa Built-in. SHENZHEN, China, Sept. 21, 2020 /PRNewswire/ -- Amazfit Band 5, a smart wrist band, launched as the latest offering of Huami to the excellence of Amazfit wearable lineup. Amazfit Band 5 featur...
2020-09-22 00:00
6185
![Amazfit Band 5 Launched with Blood Oxygen Saturation, 15-day Battery Life[1] at 49.9USD[2] on Sept. 21st, and Amazon Alexa Built-in[3] Coming Soon](https://photos.prnasia.com/prnvar/20200917/2919079-1)
Zhongchao Inc. Reports the First Half of Fiscal Year 2020 Financial Results
SHANGHAI, Sept. 21, 2020 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced its unaudited financial results for the ...
2020-09-21 21:21
6816
Ortho Awarded BARDA Contract to Accelerate Antigen Test Development and Additional SARS-CoV-2 Antibody Test Milestones
RARITAN, N.J., Sept. 21, 2020 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced its continued collaboration with the Biomedical Advanced Research and Development Authority ( BARDA), part of the Office of the Assistant Secretary for Preparedness an...
2020-09-21 21:00
2233
China Pharmaceutical Holdings Co., Ltd. Has Obtained Multiple Certifications for Its Masks
HAIKOU CITY, China, Sept. 21, 2020 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced that the masks produced by ...
2020-09-21 20:30
14024
Harbour BioMed Announces Two China NMPA Clearances for Clinical Trials for Phase I & Combination Therapy of Next Generation Anti-CTLA-4 Antibody for Treatment of Solid Tumors
CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, Sept. 21, 2020 /PRNewswire/ -- Harbour BioMed (HBM), a global, clinical-stage, innovative biopharmaceutical company announced approval of two Investigational New Drug (IND) applications by the China National Medical Products Administr...
2020-09-21 20:12
3998
I-Mab Announces China NMPA Clearance for Phase 1 Clinical Trial of Lemzoparlimab in Relapsed or Refractory Advanced Lymphoma
SHANGHAI and GAITHERSBURG, Md., Sept. 21, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the Center for Drug Evaluation (CDE) of the China ...
2020-09-21 20:00
5940
PharmAbcine expands partnership with Samsung Biologics for PMC-403
DAEJEON, South Korea, Sept. 21, 2020 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks) entered into a strategic partnership with Samsung Biologics (KRX: 207940.KS) for the development and manufacturing of PMC-403 pipeline, the next generation therapeutic antibody candidate to treat neovascular ...
2020-09-21 20:00
1726
Week's Top Stories
Most Reposted
QDX Co-Founder Giuseppe Barca Awarded Prestigious Gordon Bell Prize, Pioneering Advancements in Drug Discovery Technology
[Picked up by 303 media titles]
2024-11-26 18:49ITAP 2024 sets the stage for a more connected advanced factory ecosystem with focus on AI, advanced robotics and sustainability
[Picked up by 296 media titles]
2024-11-28 17:24Southeast Asian Consumers Raise Online Security Concerns, New GSMA Survey Shows
[Picked up by 296 media titles]
2024-11-26 13:00MediSun Energy Raises $8.75M Seed Round with Vynn Capital to Drive MENA Expansion and Advance Osmotic Energy Innovation
[Picked up by 280 media titles]
2024-11-25 10:00
Announcement of "Cyber Sousa Award" Winners of the 16th Xiamen International Animation Festival
[Picked up by 272 media titles]
2024-11-26 16:48
Most Read
Chinese path to modernization a model for Global South, experts say
2024-11-23 15:35
12916
SUNLU Formnext 2024 Event Highlights: From Functional Filaments to FilaDryer E2
2024-11-23 21:00
9000
Innovative technology and applications recognised with Hong Kong ICT Awards 2024
2024-11-23 02:02
8155
